Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib significantly improved hair loss and lesions in a patient with overlapping autoimmune disorders.

Drug repurposing shows promise for treating many medical conditions.

Flibanserin's effectiveness for low sexual desire in premenopausal women may vary based on hormone levels, with normal hormone levels showing better responses.

RY-023, a specific drug, can improve early stage memory learning without affecting general activity in rats, but it's less effective for later learning stages and doesn't impact memory recall.

Starting 5-alpha reductase inhibitors does not significantly increase the risk of rhabdomyolysis in older men, but is linked to a higher risk of muscle conditions.

Using hair loss drugs finasteride and dutasteride may cause sexual side effects.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

Doxycycline can effectively treat hair loss caused by EGFR inhibitors.

Adalimumab improved folliculitis decalvans in most patients.

Myricetin shows promise as an anticancer agent by reducing inflammation and enhancing drug effectiveness.

Keratin-based hydrogels with calcium are effective for delivering anti-fibrotic drugs.

Injectable platelet-rich fibrin improves hair growth and reduces hair loss in women.

Three specific 4-azasteroid-2-oximes showed strong enzyme inhibition, but less than finasteride.

BRL 7660, once studied for male contraception, showed promise as an acne treatment but was not developed further due to competing drugs.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

The compound 4c showed strong potential as an anticancer agent.

The effect of GLP-1 RAs on erectile function is unclear and needs more research.

Finasteride may help prevent prostate cancer.

Retinoic acid is not linked to hair loss from fluconazole use.

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

MK-386 lowers DHT in blood and skin but not in semen.

5α-reductase inhibitors do not improve survival in oesophageal and gastric cancer patients.

Filgotinib completely reversed hair loss in a patient with rheumatoid arthritis and alopecia universalis.

ZD1839 (Iressa) causes skin and hair side effects, treatable with tretinoin cream and minocycline.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

A compound from Calophyllum inophyllum L. leaf may help treat non-small cell lung cancer.

Finasteride may reduce heart damage in rats.

The conclusion is that a new test was created to find substances that affect specific ion channels, and it works well for drug discovery.